XML 26 R43.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation - Additional Information (Detail) (USD $)
3 Months Ended 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Sep. 30, 2012
Sep. 30, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Options granted and outstanding to purchase 1,914,794   1,910,794 729,096
Options granted (4,000)   1,229,500  
Stock-based compensation expense $ 395,674 $ 251,878    
Fair value of the options granted 6,023 1,392,584    
Intrinsic value of the options exercised 0 0    
Arrowhead [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Pre-tax compensation expense 3,356,689      
Weighted average period to recognize pre-tax compensation expense 2 years 10 months 24 days      
Calando Pharmaceuticals, Inc. [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Fair value of the options granted 0 33,690    
Pre-tax compensation expense $ 53,624      
Weighted average period to recognize pre-tax compensation expense 2 years 6 months      
2000 Stock Option Plan [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares reserve for issuance 153,200      
Options granted and outstanding to purchase 152,900      
2004 Equity Incentive Plan [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares reserve for issuance 1,965,860      
Options granted and outstanding to purchase 1,510,694      
Options granted outside of Equity Incentive plans 251,200      
Options granted 4,000